Cargando…
RECQ1 Promotes Stress Resistance and DNA Replication Progression Through PARP1 Signaling Pathway in Glioblastoma
Glioblastoma (GBM) is the most common aggressive primary malignant brain tumor, and patients with GBM have a median survival of 20 months. Clinical therapy resistance is a challenging barrier to overcome. Tumor genome stability maintenance during DNA replication, especially the ability to respond to...
Autores principales: | Zhang, Jing, Lian, Hao, Chen, Kui, Pang, Ying, Chen, Mu, Huang, Bingsong, Zhu, Lei, Xu, Siyi, Liu, Min, Zhong, Chunlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350743/ https://www.ncbi.nlm.nih.gov/pubmed/34381789 http://dx.doi.org/10.3389/fcell.2021.714868 |
Ejemplares similares
-
Human RecQ Helicases in DNA Double-Strand Break Repair
por: Lu, Huiming, et al.
Publicado: (2021) -
Flap endonuclease 1 and DNA-PKcs synergistically participate in stabilizing replication fork to encounter replication stress in glioma cells
por: Zhang, Jing, et al.
Publicado: (2022) -
A PARP1-related prognostic signature constructing and PARP-1 inhibitors screening for glioma
por: Li, Hui, et al.
Publicado: (2022) -
PARP1 Upregulation in Recurrent Oral Cancer and Treatment Resistance
por: Wang, Feifei, et al.
Publicado: (2022) -
Rev7 and 53BP1/Crb2 prevent RecQ helicase-dependent hyper-resection of DNA double-strand breaks
por: Leland, Bryan A, et al.
Publicado: (2018)